January |
Measurement and rating
An in-depth look at quality measurement of providers and health plans |
February |
Sexual health
STDs, coverage of treatment of erectile dysfunction, and other issues at the crossroad of sexual health and managed care |
March |
Biosimilars
Also: Update on generics |
April |
Telemedicine
|
May |
Cancer
Also: Spotlight on real-world evidence in oncology based on news from AACR and in the lead up to ASCO. |
June |
Niche diseases and specialty medications
|
July |
General interest
|
August |
The 10 Most Important People in Managed Care — and other lists
|
September |
How Doctors Are Paid Now, And Why It Has to Change
|
October |
Autoimmune diseases
|
November |
Medical directors and chief medical officers
|
December |
Our 3rd Annual YIP (Year in Preview) issue
|
Read Next
FiercePharma has compiled a list of the top 15 cancer medications that are expected to dominate the oncology market in 2022.
Joint venture plans are starting to demonstrate their ability to implement clinical management and financial management reforms. A JV health plan replaces the offloading of financial risk by health plans to ill-equipped providers with an executive-level cost management committee stated jointly by the hospital and payer.
For several days, a middle-aged woman who claimed to be a doctor in training roamed the halls of Brigham and Women’s Hospital in Boston, dressed in scrubs, asking questions at a lecture, attending patient rounds, and observing surgical procedures, according to a report in the Boston Globe

Paul Lendner ist ein praktizierender Experte im Bereich Gesundheit, Medizin und Fitness. Er schreibt bereits seit über 5 Jahren für das Managed Care Mag. Mit seinen Artikeln, die einen einzigartigen Expertenstatus nachweisen, liefert er unseren Lesern nicht nur Mehrwert, sondern auch Hilfestellung bei ihren Problemen.